Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CoreWeave, Inc. (Nasdaq: CRWV) SEC filings page provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. As a publicly traded Software - Infrastructure company focused on AI cloud services, CoreWeave uses its filings to describe material agreements, financing arrangements, and significant corporate events.
In its Form 8-K filings, CoreWeave has reported material definitive agreements such as master services agreements and order forms with OpenAI, Meta Platforms, Inc., and NVIDIA Corporation, which govern access to cloud computing capacity and reserved capacity arrangements. The company has also disclosed credit agreements and delayed draw term loan facilities used to finance capital expenditures for GPU servers, infrastructure, and systems that support strategic customer contracts.
CoreWeave’s filings include detailed descriptions of its debt and capital structure, such as senior notes, revolving credit facilities, and convertible senior notes due 2031. These documents outline terms like interest rates, maturity dates, conversion features, capped call transactions, guarantees by subsidiaries, and financial covenants. Investors can review these filings to understand how CoreWeave funds its AI infrastructure and manages potential dilution.
Other 8-K filings cover topics such as the termination of a proposed merger agreement, changes in classification of equity related to preferred stock put rights, and the registration of Class A common stock on The Nasdaq Stock Market LLC under the symbol CRWV. Results of operations and financial condition for specific quarters are also furnished via 8-K exhibits.
On Stock Titan, AI-powered tools can help summarize lengthy CoreWeave filings, highlight key terms in documents like credit agreements and indentures, and surface information on topics such as material customer contracts, new financing facilities, and significant corporate events. Users can quickly locate references to items like convertible notes, capped call transactions, or major AI infrastructure commitments without reading every page.
CoreWeave, Inc. entered into a landmark $8.5 billion delayed draw term loan facility through its subsidiary CoreWeave Compute Acquisition Co. VIII, LLC to finance GPU servers and related infrastructure for a major AI customer contract. The DDTL 4.0 Facility allows multiple draws until June 2027 and matures in March 2032, with borrowings at SOFR plus 2.25% for floating-rate loans or about 5.9% for a fixed-rate tranche, and a 0.50% annual fee on undrawn amounts. The facility is secured by substantially all assets of the borrower group, includes a minimum 1.15x debt service coverage ratio covenant, and is guaranteed on a limited recourse basis by CoreWeave. The company highlights that the financing achieved investment-grade ratings of A3 and A (low), and notes it contributes to approximately $28 billion of equity and debt financing commitments raised over the past 12 months to expand its high-performance AI cloud footprint.
CRWV reports multiple planned and executed 10b5-1 sales of Common stock by affiliated holders and trusts across January–March 2026. Transactions range from small lots (500 shares) to larger blocks (up to 300,000 shares), with examples including a 303,929-share sale by Fidelity Charitable and several trustee/entity sales for Brannin McBee and related trusts.
CRWV filings report multiple Regulation 144 resale transactions by affiliated holders and trusts. The excerpt lists numerous 10b5-1 programmed sales and charitable transfers of Common stock, including large blocks such as 303,929 shares for Fidelity Charitable and a 300,000-share sale by an affiliated holder. Sales are shown with per-sale proceeds in dollars and specific trade dates through March 2026.
CRWV filed multiple Form 144 notices reporting proposed resale of Common Stock by several holders, primarily under 10b5-1 plans. The excerpt lists numerous transactions and quantities (examples include a 303,929-share sale and several large blocks of 100,000–300,000 shares) with execution dates in Jan–Mar 2026.
The filings show sales by named trusts and individuals through Morgan Stanley Smith Barney LLC and other brokers; proceeds for individual trades are shown in the excerpt. These are notices of proposed resales rather than corporate issuances.
CRWV proposed sales of Common shares by multiple holders, primarily executed under 10b5-1 plans. The filing lists numerous transactions between 01/05/2026 and 03/30/2026, with individual sales shown (examples: 300,000 shares for Brannin McBee on 03/09/2026, proceeds $21,782,820.00). The notice supplies per-transaction share counts and gross proceeds for reporting of resale activity.
CRWV submitted a Form 144 reporting planned sales of Common Stock, listing a 100,000 shares block with an aggregate value of $7,481,000. The notice references numerous 10b5-1 program sales by multiple holders and a large charitable sale of 303,929 shares for $22,930,105.76.
Sales and holder names are listed by date, with a dated snapshot showing 419,028,081 shares and a reporting date of 03/30/2026.
CoreWeave, Inc.’s CEO and President Michael N. Intrator reported net stock sales alongside a small share conversion. On March 25, 2026, an entity associated with him, Omnadora Capital LLC, converted 50,000 shares of Class B Common Stock into 50,000 shares of Class A Common Stock at an exercise price of $0.0000 per share, then sold those 50,000 Class A shares in multiple open-market transactions.
On the same date, Intrator directly sold an additional 32,456 shares of Class A Common Stock in several open-market trades at prices reported between about $85.60 and $88.25 per share, for total reported sales of 82,456 Class A shares. At least one sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2025. Following these transactions, he continued to hold 5,666,501 Class A shares directly, along with substantial Class B holdings convertible into Class A shares.
The Vanguard Group files an amendment to a Schedule 13G for CoreWeave Inc reporting zero beneficial ownership. The filing states that following an internal realignment on January 12, 2026, certain Vanguard subsidiaries will report holdings separately and Vanguard no longer reports beneficial ownership of the shares. The filing lists Amount beneficially owned: 0 and Percent of class: 0%.
CoreWeave, Inc.’s Chief Development Officer Brannin McBee reported a set of trust-related transactions that converted Class B into Class A shares and then sold the resulting Class A stock. Grantor retained annuity trusts named Canis Major 2025 GRAT and Canis Minor 2025 GRAT converted an aggregate 22,915 shares of Class B Common Stock into the same number of Class A shares at a conversion price of $0.00 per share. Those trusts then sold 22,915 shares of Class A Common Stock in multiple open-market transactions at weighted-average prices such as $81.0557, $81.8776, $82.9810, $83.8088 and $84.7347 per share. A footnote states these sales were effected under a Rule 10b5-1 trading plan adopted on November 17, 2025. McBee continues to have indirect exposure to CoreWeave through several trusts and LLCs that hold Class B shares convertible into Class A, as well as additional indirect Class A holdings.
CoreWeave, Inc.’s Chief Development Officer Brannin McBee converted 143,750 shares of Class B Common Stock into an equal number of Class A shares on March 23, 2026, then sold 143,750 Class A shares in multiple open-market transactions at weighted-average prices in the low-to-mid $80 range pursuant to a Rule 10b5-1 trading plan adopted on November 17, 2025.
After these transactions, McBee directly owns 248,664 Class A shares. He also continues to have substantial Class B holdings, including 7,691,660 shares directly, 2,196,975 through his spouse, and 3,830,595 through the Brannin J. McBee 2022 Irrevocable Trust.